Skip to content

Study to Evaluate the Feasibility of Integrating the Point-of-care Testing for Sexually Transmitted Infections and HIV Into Community-based Clinics for MSM and TGW in Thailand

The Thai Red Cross AIDS Research Centre

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03580512
Enrollment
2000
Registered
2018-07-09
Start date
2017-04-15
Completion date
2024-03-15
Last updated
2024-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men Who Have Sex With Men and Transgender Women

Brief summary

This will be a prospective study that will enroll up to 2000 MSM and TG from community-based clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.

Detailed description

Eligible participants will be followed up until the completion of a 12-month period. All participants will be followed up every 3 months. An additional follow up visit at month 1 will be made for participants who PrEP is initiated at entry visit (those who already received PrEP prior to the study will not need the additional visit). Study Sites The study will take place at the following community-based clinics: 1. SWING DIC, Bangkok, Thailand 2. RSAT DIC, Bangkok, Thailand 3. SWING DIC, Chonburi, Thailand 4. Sisters DIC, Chonburi, Thailand 5. Mplus DIC, Chiang Mai, Thailand 6. RSAT DIC, Songkhla, Thailand

Interventions

None listed

Sponsors

Thai Red Cross AIDS Research Centre
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum

Inclusion criteria

1. Thai nationality 2. Age ≥ 18 years old 3. Men or transgender women who have sex with men 4. Have at least one of the following risks for HIV acquisition in the past 6 months: * Any unprotected receptive anal sex * More than 5 sexual partners, regardless of condom use and serostatus * History of syphilis, chlamydia or gonorrhea diagnosed or treated * Any stimulant drug use 5. Have signed the consent form

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Proportion of participants who receive same-day diagnosis of HIV infection in community-based clinics1 years
Proportion of participants who receive same-day diagnosis and treatment of CT/NG in community-based clinics1 years

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026